To investigate the distribution of CD47 and PD-L1 on tumor and immune cells within peripheral blood and the tumor microenvironment, we evaluated matched blood and primary and/or metastatic tissue samples from CTC-positive patients. This evidence concerns the gene CD274 and neoplasm.